牛牛AI助理已提取核心訊息
James Patrick Kelly, EVP, CFO, and Treasurer of Novavax Inc, completed a stock transaction involving the company's common stock on March 7, 2024. Kelly executed a sale of 5,905 shares at a price of $5.61 per share, resulting in a total transaction value of $33,127.05. Following this transaction, Kelly holds a total of 10,903 shares of Novavax common stock. The sale was part of a transaction that also included the exercise or conversion of derivative securities, which resulted in the acquisition of 12,224 shares on the same date.
James Patrick Kelly, EVP, CFO, and Treasurer of Novavax Inc, completed a stock transaction involving the company's common stock on March 7, 2024. Kelly executed a sale of 5,905 shares at a price of $5.61 per share, resulting in a total transaction value of $33,127.05. Following this transaction, Kelly holds a total of 10,903 shares of Novavax common stock. The sale was part of a transaction that also included the exercise or conversion of derivative securities, which resulted in the acquisition of 12,224 shares on the same date.
Novavax Inc執行副總裁、首席財務官兼財務主管詹姆斯·帕特里克·凱利於2024年3月7日完成了一項涉及公司普通股的股票交易。凱利以每股5.61美元的價格出售了5,905股股票，總交易價值爲33,127.05美元。在這筆交易之後，凱利共持有10,903股Novavax普通股。此次出售是交易的一部分，該交易還包括行使或轉換衍生證券，該交易導致同日收購了12,224股股票。
Novavax Inc執行副總裁、首席財務官兼財務主管詹姆斯·帕特里克·凱利於2024年3月7日完成了一項涉及公司普通股的股票交易。凱利以每股5.61美元的價格出售了5,905股股票，總交易價值爲33,127.05美元。在這筆交易之後，凱利共持有10,903股Novavax普通股。此次出售是交易的一部分，該交易還包括行使或轉換衍生證券，該交易導致同日收購了12,224股股票。
有用
沒用